Report Detail

Pharma & Healthcare Global Neuroendocrine Carcinoma Market Professional Survey Report 2019

  • RnM3743767
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Neuroendocrine Carcinoma Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of Neuroendocrine Carcinoma

      • 1.1 Definition of Neuroendocrine Carcinoma
      • 1.2 Neuroendocrine Carcinoma Segment by Type
        • 1.2.1 Global Neuroendocrine Carcinoma Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Chemotherapy
        • 1.2.3 Somatostatin Analogs
        • 1.2.4 Targeted Therapy
      • 1.3 Neuroendocrine Carcinoma Segment by Applications
        • 1.3.1 Global Neuroendocrine Carcinoma Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinics
        • 1.3.4 Oncology Centres
        • 1.3.5 Ambulatory Surgery Centres
      • 1.4 Global Neuroendocrine Carcinoma Overall Market
        • 1.4.1 Global Neuroendocrine Carcinoma Revenue (2014-2025)
        • 1.4.2 Global Neuroendocrine Carcinoma Production (2014-2025)
        • 1.4.3 North America Neuroendocrine Carcinoma Status and Prospect (2014-2025)
        • 1.4.4 Europe Neuroendocrine Carcinoma Status and Prospect (2014-2025)
        • 1.4.5 China Neuroendocrine Carcinoma Status and Prospect (2014-2025)
        • 1.4.6 Japan Neuroendocrine Carcinoma Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Neuroendocrine Carcinoma Status and Prospect (2014-2025)
        • 1.4.8 India Neuroendocrine Carcinoma Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Carcinoma
      • 2.3 Manufacturing Process Analysis of Neuroendocrine Carcinoma
      • 2.4 Industry Chain Structure of Neuroendocrine Carcinoma

      3 Development and Manufacturing Plants Analysis of Neuroendocrine Carcinoma

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Neuroendocrine Carcinoma Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Neuroendocrine Carcinoma
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Neuroendocrine Carcinoma Production and Capacity Analysis
      • 4.2 Neuroendocrine Carcinoma Revenue Analysis
      • 4.3 Neuroendocrine Carcinoma Price Analysis
      • 4.4 Market Concentration Degree

      5 Neuroendocrine Carcinoma Regional Market Analysis

      • 5.1 Neuroendocrine Carcinoma Production by Regions
        • 5.1.1 Global Neuroendocrine Carcinoma Production by Regions
        • 5.1.2 Global Neuroendocrine Carcinoma Revenue by Regions
      • 5.2 Neuroendocrine Carcinoma Consumption by Regions
      • 5.3 North America Neuroendocrine Carcinoma Market Analysis
        • 5.3.1 North America Neuroendocrine Carcinoma Production
        • 5.3.2 North America Neuroendocrine Carcinoma Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Neuroendocrine Carcinoma Import and Export
      • 5.4 Europe Neuroendocrine Carcinoma Market Analysis
        • 5.4.1 Europe Neuroendocrine Carcinoma Production
        • 5.4.2 Europe Neuroendocrine Carcinoma Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Neuroendocrine Carcinoma Import and Export
      • 5.5 China Neuroendocrine Carcinoma Market Analysis
        • 5.5.1 China Neuroendocrine Carcinoma Production
        • 5.5.2 China Neuroendocrine Carcinoma Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Neuroendocrine Carcinoma Import and Export
      • 5.6 Japan Neuroendocrine Carcinoma Market Analysis
        • 5.6.1 Japan Neuroendocrine Carcinoma Production
        • 5.6.2 Japan Neuroendocrine Carcinoma Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Neuroendocrine Carcinoma Import and Export
      • 5.7 Southeast Asia Neuroendocrine Carcinoma Market Analysis
        • 5.7.1 Southeast Asia Neuroendocrine Carcinoma Production
        • 5.7.2 Southeast Asia Neuroendocrine Carcinoma Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Neuroendocrine Carcinoma Import and Export
      • 5.8 India Neuroendocrine Carcinoma Market Analysis
        • 5.8.1 India Neuroendocrine Carcinoma Production
        • 5.8.2 India Neuroendocrine Carcinoma Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Neuroendocrine Carcinoma Import and Export

      6 Neuroendocrine Carcinoma Segment Market Analysis (by Type)

      • 6.1 Global Neuroendocrine Carcinoma Production by Type
      • 6.2 Global Neuroendocrine Carcinoma Revenue by Type
      • 6.3 Neuroendocrine Carcinoma Price by Type

      7 Neuroendocrine Carcinoma Segment Market Analysis (by Application)

      • 7.1 Global Neuroendocrine Carcinoma Consumption by Application
      • 7.2 Global Neuroendocrine Carcinoma Consumption Market Share by Application (2014-2019)

      8 Neuroendocrine Carcinoma Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Chiasma
        • 8.3.1 Chiasma Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.3.2 Chiasma Product Introduction, Application and Specification
        • 8.3.3 Chiasma Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Ipsen
        • 8.4.1 Ipsen Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.4.2 Ipsen Product Introduction, Application and Specification
        • 8.4.3 Ipsen Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Abbvie
        • 8.5.1 Abbvie Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.5.2 Abbvie Product Introduction, Application and Specification
        • 8.5.3 Abbvie Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Valeant
        • 8.6.1 Valeant Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.6.2 Valeant Product Introduction, Application and Specification
        • 8.6.3 Valeant Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Jubilant
        • 8.7.1 Jubilant Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.7.2 Jubilant Product Introduction, Application and Specification
        • 8.7.3 Jubilant Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Teva
        • 8.8.1 Teva Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.8.2 Teva Product Introduction, Application and Specification
        • 8.8.3 Teva Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 F.Hoffmann-La Roche
        • 8.9.1 F.Hoffmann-La Roche Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.9.2 F.Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.9.3 F.Hoffmann-La Roche Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Advanced Accelerator
        • 8.10.1 Advanced Accelerator Neuroendocrine Carcinoma Production Sites and Area Served
        • 8.10.2 Advanced Accelerator Product Introduction, Application and Specification
        • 8.10.3 Advanced Accelerator Neuroendocrine Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Mateon
      • 8.12 Lexicon

      9 Development Trend of Analysis of Neuroendocrine Carcinoma Market

      • 9.1 Global Neuroendocrine Carcinoma Market Trend Analysis
        • 9.1.1 Global Neuroendocrine Carcinoma Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Neuroendocrine Carcinoma Regional Market Trend
        • 9.2.1 North America Neuroendocrine Carcinoma Forecast 2019-2025
        • 9.2.2 Europe Neuroendocrine Carcinoma Forecast 2019-2025
        • 9.2.3 China Neuroendocrine Carcinoma Forecast 2019-2025
        • 9.2.4 Japan Neuroendocrine Carcinoma Forecast 2019-2025
        • 9.2.5 Southeast Asia Neuroendocrine Carcinoma Forecast 2019-2025
        • 9.2.6 India Neuroendocrine Carcinoma Forecast 2019-2025
      • 9.3 Neuroendocrine Carcinoma Market Trend (Product Type)
      • 9.4 Neuroendocrine Carcinoma Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Neuroendocrine Carcinoma Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.
        The somatostatin analogs segment by treatment type is expected to witness high traction in the coming years.

        The global Neuroendocrine Carcinoma market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Neuroendocrine Carcinoma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroendocrine Carcinoma market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Neuroendocrine Carcinoma in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Neuroendocrine Carcinoma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Chiasma
        Ipsen
        Abbvie
        Valeant
        Jubilant
        Teva
        F.Hoffmann-La Roche
        Advanced Accelerator
        Mateon
        Lexicon

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Chemotherapy
        Somatostatin Analogs
        Targeted Therapy

        Segment by Application
        Hospital
        Clinics
        Oncology Centres
        Ambulatory Surgery Centres


        Summary:
        Get latest Market Research Reports on Neuroendocrine Carcinoma. Industry analysis & Market Report on Neuroendocrine Carcinoma is a syndicated market report, published as Global Neuroendocrine Carcinoma Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Neuroendocrine Carcinoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,801.12
        4,201.67
        5,602.23
        3,172.24
        4,758.36
        6,344.48
        377,594.00
        566,391.00
        755,188.00
        248,805.90
        373,208.85
        497,611.80
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report